The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy
Authors
Keywords
-
Journal
Journal of Pathology Clinical Research
Volume 8, Issue 5, Pages 481-491
Publisher
Wiley
Online
2022-07-15
DOI
10.1002/cjp2.288
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes
- (2021) Shixiang Wang et al. PLoS Genetics
- Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes
- (2020) Christopher M. Heaphy et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN)
- (2020) Tamara Jamaspishvili et al. JNCI-Journal of the National Cancer Institute
- Single-cell circulating tumor cell analysis reveals genomic instability as a distinctive feature of aggressive prostate cancer
- (2020) Paymaneh D Malihi et al. CLINICAL CANCER RESEARCH
- Genome rearrangements associated with aberrant telomere maintenance
- (2020) Ragini Bhargava et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Implications of the United States Preventive Services Task Force Recommendations on Prostate Cancer Stage Migration
- (2020) Iris Y. Sheng et al. Clinical Genitourinary Cancer
- Analysis of Telomere Lengths in p53 Signatures and Incidental Serous Tubal Intraepithelial Carcinomas Without Concurrent Ovarian Cancer
- (2019) Shiho Asaka et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- PTEN loss with ERG -Negative Status is Associated with Lethal Disease after Radical Prostatectomy
- (2019) Nora M. Haney et al. JOURNAL OF UROLOGY
- Clinical implications of PTEN loss in prostate cancer
- (2018) Tamara Jamaspishvili et al. Nature Reviews Urology
- Shelterin-Mediated Telomere Protection
- (2018) Titia de Lange Annual Review of Genetics
- Quantification of telomere features in tumor tissue sections by an automated 3D imaging-based workflow
- (2017) Manuel Gunkel et al. METHODS
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
- (2016) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men
- (2016) Ashley E. Ross et al. EUROPEAN UROLOGY
- SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort
- (2016) Michael H. Johnson et al. JOURNAL OF UROLOGY
- Low Intratumoral Mast Cells Are Associated With a Higher Risk of Prostate Cancer Recurrence
- (2016) Heidi A. Hempel et al. PROSTATE
- Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies
- (2016) Mohammad A. Jafri et al. Genome Medicine
- A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer
- (2015) Thomas U. Ahearn et al. JNCI-Journal of the National Cancer Institute
- Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial
- (2015) Christopher M. Heaphy et al. PROSTATE
- A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer
- (2015) Thomas U. Ahearn et al. JNCI-Journal of the National Cancer Institute
- Prostate Cancer Cell Telomere Length Variability and Stromal Cell Telomere Length as Prognostic Markers for Metastasis and Death
- (2013) C. M. Heaphy et al. Cancer Discovery
- Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer
- (2012) Alcides Chaux et al. MODERN PATHOLOGY
- The CAPRA-S score
- (2011) Matthew R. Cooperberg et al. CANCER
- PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
- (2011) T. L. Lotan et al. CLINICAL CANCER RESEARCH
- α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study
- (2011) Marc Barry et al. PROSTATE
- Immunohistochemical Expression of BRCA1 and Lethal Prostate Cancer
- (2010) M. Fiorentino et al. CANCER RESEARCH
- Aberrant Cytoplasmic Expression of p63 and Prostate Cancer Mortality
- (2009) P. K. Dhillon et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?
- (2009) Jennifer R. Stark et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started